Anvendelse af prostaglandin (PGE2) selektive receptor 4 (EP4) agonister til behandling af akut og kronisk nyresvigt
This invention is directed to methods and compositions of teating acute or chronic renal failure or dysfunction, or conditions caused thereby comprising administering prostaglandin agonists, which ae EP4 receptor selective prostaglandin agonists.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Danish |
Published |
28.08.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!